176 related articles for article (PubMed ID: 15578963)
1. Voltage-gated sodium channels and pain.
Priestley T
Curr Drug Targets CNS Neurol Disord; 2004 Dec; 3(6):441-56. PubMed ID: 15578963
[TBL] [Abstract][Full Text] [Related]
2. [The role of voltage-gated sodium channels in neuropathic pain].
Dong H; Hu SJ
Sheng Li Ke Xue Jin Zhan; 2005 Jan; 36(1):61-3. PubMed ID: 15881349
[No Abstract] [Full Text] [Related]
3. Voltage-gated sodium channels and hyperalgesia.
Lai J; Porreca F; Hunter JC; Gold MS
Annu Rev Pharmacol Toxicol; 2004; 44():371-97. PubMed ID: 14744251
[TBL] [Abstract][Full Text] [Related]
4. The role of voltage-gated sodium channels in neuropathic pain.
Lai J; Hunter JC; Porreca F
Curr Opin Neurobiol; 2003 Jun; 13(3):291-7. PubMed ID: 12850213
[TBL] [Abstract][Full Text] [Related]
5. Voltage-gated sodium channel blockers for the treatment of chronic pain.
Matulenko MA; Scanio MJ; Kort ME
Curr Top Med Chem; 2009; 9(4):362-76. PubMed ID: 19442207
[TBL] [Abstract][Full Text] [Related]
6. The role of tetrodotoxin-resistant sodium channels in pain states: are they the next target for analgesic drugs?
Silos-Santiago I
Curr Opin Investig Drugs; 2008 Jan; 9(1):83-9. PubMed ID: 18183535
[TBL] [Abstract][Full Text] [Related]
7. Voltage-gated Na+ channels in neuropathic pain.
Hargus NJ; Patel MK
Expert Opin Investig Drugs; 2007 May; 16(5):635-46. PubMed ID: 17461737
[TBL] [Abstract][Full Text] [Related]
8. Voltage-gated sodium channel blockers for the treatment of neuropathic pain.
Cummins TR; Rush AM
Expert Rev Neurother; 2007 Nov; 7(11):1597-612. PubMed ID: 17997706
[TBL] [Abstract][Full Text] [Related]
9. Voltage-gated sodium channels and pain pathways.
Wood JN; Boorman JP; Okuse K; Baker MD
J Neurobiol; 2004 Oct; 61(1):55-71. PubMed ID: 15362153
[TBL] [Abstract][Full Text] [Related]
10. Neurological perspectives on voltage-gated sodium channels.
Eijkelkamp N; Linley JE; Baker MD; Minett MS; Cregg R; Werdehausen R; Rugiero F; Wood JN
Brain; 2012 Sep; 135(Pt 9):2585-612. PubMed ID: 22961543
[TBL] [Abstract][Full Text] [Related]
11. Sodium Channels in Human Pain Disorders: Genetics and Pharmacogenomics.
Dib-Hajj SD; Waxman SG
Annu Rev Neurosci; 2019 Jul; 42():87-106. PubMed ID: 30702961
[TBL] [Abstract][Full Text] [Related]
12. Voltage-gated sodium channels in neurological disorders.
Chahine M; Chatelier A; Babich O; Krupp JJ
CNS Neurol Disord Drug Targets; 2008 Apr; 7(2):144-58. PubMed ID: 18537643
[TBL] [Abstract][Full Text] [Related]
13. Sodium channels and nociception: recent concepts and therapeutic opportunities.
Krafte DS; Bannon AW
Curr Opin Pharmacol; 2008 Feb; 8(1):50-6. PubMed ID: 17964852
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain.
Porreca F; Lai J; Bian D; Wegert S; Ossipov MH; Eglen RM; Kassotakis L; Novakovic S; Rabert DK; Sangameswaran L; Hunter JC
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7640-4. PubMed ID: 10393873
[TBL] [Abstract][Full Text] [Related]
15. Blockade of neuropathic pain by antisense targeting of tetrodotoxin-resistant sodium channels in sensory neurons.
Lai J; Hunter JC; Ossipov MH; Porreca F
Methods Enzymol; 2000; 314():201-13. PubMed ID: 10565014
[No Abstract] [Full Text] [Related]
16. Structure, function and pharmacology of voltage-gated sodium channels.
Denac H; Mevissen M; Scholtysik G
Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):453-79. PubMed ID: 11138838
[TBL] [Abstract][Full Text] [Related]
17. Blockers of voltage-gated sodium channels for the treatment of central nervous system diseases.
Tarnawa I; Bölcskei H; Kocsis P
Recent Pat CNS Drug Discov; 2007 Jan; 2(1):57-78. PubMed ID: 18221218
[TBL] [Abstract][Full Text] [Related]
18. Voltage-gated sodium channels: therapeutic targets for pain.
Dib-Hajj SD; Black JA; Waxman SG
Pain Med; 2009 Oct; 10(7):1260-9. PubMed ID: 19818036
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of the voltage-gated sodium channel beta2 subunit in neuropathic pain models: characterization of expression in injured and non-injured primary sensory neurons.
Pertin M; Ji RR; Berta T; Powell AJ; Karchewski L; Tate SN; Isom LL; Woolf CJ; Gilliard N; Spahn DR; Decosterd I
J Neurosci; 2005 Nov; 25(47):10970-80. PubMed ID: 16306410
[TBL] [Abstract][Full Text] [Related]
20. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels.
Catterall WA; Goldin AL; Waxman SG
Pharmacol Rev; 2005 Dec; 57(4):397-409. PubMed ID: 16382098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
